Skip to main content
HYDROGEN STUDIESPOWERED BY ECHO WATER

Hydrogen Gas Therapy Improves Survival After Brain Hemorrhage in Rats

Hydrogen gas therapy improves survival rate and neurological deficits in subarachnoid hemorrhage rats: a pilot study

Research hubs: Brain & Nervous System · Cardiovascular System

This research was done in animals. Results in animals often don't carry over to people.

Scientific visualization of hydrogen therapy research for Hydrogen gas therapy improves survival rate and neurological deficits in subarachnoid hemorrhage rats: a pilot study
Evidence type
Animal study (rat)
Authors
JohnH Zhang, Richard Camara, Nathanael Matei, Justin Camara, Budbazar Enkhjargal, Jiping Tang
Journal
Medical Gas Research
Year
2019
Study Type
Rat
Delivery
Gas
Dose
66% H2 gas at 3 L/min for 2 hours at 0.5, 8, and 18 hours after SAH
H₂ concentration
66% H2 gas
Duration
3 days
Outcome
Positive
Peer Reviewed
Yes
Cited by
16 (OpenAlex, as of November 2026)
Country
United States

TL;DR

High dose hydrogen gas treatment significantly increased survival rates and improved brain function in rats after a brain hemorrhage.

Key Finding

High-dose hydrogen gas therapy administered within 18 hours of brain hemorrhage increased 72-hour survival rates and reduced neurological damage in rats.

Summary

This study tested whether hydrogen gas could help rats survive and recover from subarachnoid hemorrhage, a type of brain bleed. Researchers gave rats high-dose hydrogen gas (66% concentration) for 2 hours at different time points after the injury. The treatment improved survival rates at 72 hours and reduced brain damage, likely by reducing harmful chemical reactions, inflammation, and cell death in the brain.

Practical Takeaway

This is an early-stage animal study showing hydrogen gas may have protective effects in brain hemorrhage, but it does not yet tell us whether this would work in humans. Much more research, including human clinical trials, would be needed before any health claims could be made. The study's findings are promising enough to warrant further investigation, but current evidence is limited to rats.

Abstract (excerpt)

The high morbidity, high mortality, and significant shortage of effective therapies for subarachnoid hemorrhage (SAH) have created an urgency to discover novel therapies. Human studies in Asia have established the safety of hydrogen gas in the treatment of hepatic, renal, pulmonary, and cardiac…

Read the full abstract on PubMed